MJoTAtalks

Dr Susanna's guide to

www.MJoTA.org
click here

www.MJoTAtalks.org click here

www.drsusanna.org click here



Dr Susanna loves the countries and the peoples of Africa
 
Bookmark and Share
Diabetes news from the American Diabetes Association

Latest Top (20) News
Diabetes News
Diabetes news from the National Institutes of Health Diabetes Educators.

Latest Top (10) News
Clinical trials testing therapies for diabetes

Latest Top (10) News


Autologous Bone Marrow Transplant in Chronic Insulin Dependent Diabetic Patients
Conditions:   Diabetes Mellitus Progression;   Diabetes Complications
Intervention:   Biological: Adult Bone Marrow Stem Cells
Sponsor:   Global Cell Med
Recruiting

Tue, 19 Jun 2018 12:00:00 EDT


Biomarkers Derived From Adipose Tissue Useful for Diagnosis and Prognosis of Cardiovascular Risk (CVR) in Obese Patient
Conditions:   Metabolic Syndrome;   Diabetes Mellitus;   Inflammatory Response
Intervention:   Procedure: Bariatric surgery
Sponsor:   Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado
Enrolling by invitation

Tue, 19 Jun 2018 12:00:00 EDT


Cardiometabolic Care-team Integration Improves Outcomes in Diabetes
Condition:   Cardio-metabolic Care-Team Intervention (CMC-TI)
Intervention:   Behavioral: Cardometabolic Team Intervention
Sponsor:   Scripps Whittier Diabetes Institute
Completed

Tue, 19 Jun 2018 12:00:00 EDT


Cognitive Behavioral Therapy for African Americans With Uncontrolled Type-2 Diabetes
Condition:   Diabetes Mellitus, Type 2
Interventions:   Behavioral: Group-based Cognitive Behavioral Intervention;   Behavioral: Web-based Cognitive Behavioral Intervention;   Behavioral: Usual Care
Sponsors:   Emory University;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Not yet recruiting

Tue, 19 Jun 2018 12:00:00 EDT


Multi-Center Development of a Novel Diagnostic Test for Alzheimer's Disease
Conditions:   Alzheimer Disease;   Mild Cognitive Impairment
Intervention:   Diagnostic Test: Pramlintide challenge test
Sponsor:   Boston University
Not yet recruiting

Tue, 19 Jun 2018 12:00:00 EDT


Tai Chi Quan Improving Biochemistry and Quality of Life in Type 2 Diabetes
Condition:   Type 2 Diabetes Mellitus
Intervention:   Behavioral: Tai Chi Quan
Sponsors:   Taipei City Hospital;   National Yang Ming University
Recruiting

Tue, 19 Jun 2018 12:00:00 EDT


Triglyceride Rich Lipoproteins and Platelet Activation in Type 2 Diabetes
Condition:   Type2 Diabetes
Interventions:   Other: butter based breakfast;   Other: Chocolate spread based breakfast
Sponsor:   Hospices Civils de Lyon
Not yet recruiting

Tue, 19 Jun 2018 12:00:00 EDT


A Phase 2 Study of Cyclo-Z in Subjects With Type 2 Diabetes
Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: Cyclo-Z;   Other: Placebo
Sponsors:   NovMetaPharma Co., Ltd.;   InClin, Inc.;   FGK Clinical Research GmbH
Not yet recruiting

Mon, 18 Jun 2018 12:00:00 EDT


Arterial Hypertension in Men in the Warmia and Masuria Region
Condition:   Arterial Hypertension
Intervention:  
Sponsors:   University of Warmia and Mazury;   Zaklady Farmaceutyczne Polpharma SA / Poland
Active, not recruiting

Mon, 18 Jun 2018 12:00:00 EDT


Association of Genetic Polymorphisms With Atrial Fibrosis and Thrombogenic Substrate in Patients With Non-valvular Atrial Fibrillation
Conditions:   Atrial Fibrillation;   Thrombosis;   Stroke;   Genetic Predisposition;   Heart Diseases
Intervention:   Diagnostic Test: Biomarkers, Cardiac Magnetic Resonance Imaging, Echocardiography, Flow Mediated Dilatation, Genetic Analysis
Sponsor:   Memorial Ankara Hospital
Not yet recruiting

Mon, 18 Jun 2018 12:00:00 EDT
Don't get diabetes! Take care of yourself if you have it! Diabetes resources, click here.
FDA (Food and Drug Administration) press releases. FDA makes sure of the safety of all medicines which can be injected, breathed in, rubbed in and swallowed, in the United States of America.

Latest Top (10) News


Statement from Douglas Throckmorton, M.D., deputy center director for regulatory programs in FDA’s Center for Drug Evaluation and Research, on the agency’s response to ongoing drug shortages for critical products
Statement from Douglas Throckmorton, M.D., deputy center director for regulatory programs in FDA’s Center for Drug Evaluation and Research, on the agency’s response to ongoing drug shortages for critical products

Tue, 19 Jun 2018 15:03:00 -0400


Statement from FDA Commissioner Scott Gottlieb, M.D., on new guidance to help manufacturers implement protections against potential attacks on the U.S. food supply
FDA releases draft guidance to help food manufacturers implement the Intentional Adulteration rule under the FDA Food Safety Modernization Act

Tue, 19 Jun 2018 10:27:00 -0400


Statement from FDA Commissioner Scott Gottlieb, M.D. and FDA Deputy Commissioner Anna Abram on emerging food innovation, “cultured” food products
Statement from FDA Commissioner Scott Gottlieb, M.D. and FDA Deputy Commissioner Anna Abram on emerging food innovation, “cultured” food products

Fri, 15 Jun 2018 10:04:00 -0400


FDA approves first generic versions of Suboxone sublingual film, which may increase access to treatment for opioid dependence
: FDA approved the first generic versions of Suboxone (buprenorphine and naloxone) sublingual film (applied under the tongue) for the treatment of opioid dependence.

Thu, 14 Jun 2018 16:49:00 -0400


Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency’s efforts to better equip consumers with nutritional information about dietary fiber in their food
Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency’s efforts to better equip consumers with nutritional information about dietary fiber in their food

Thu, 14 Jun 2018 09:26:00 -0400


Statement from FDA Commissioner Scott Gottlieb, M.D., on new agency efforts to advance the patient voice in medical product development and FDA regulatory decision-making
FDA issues draft guidance on collecting patient experiences to inform the development and evaluation of medical products

Tue, 12 Jun 2018 10:44:00 -0400


Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA’s efforts to foster discovery and development of new tools to fight antimicrobial-resistant infections
The increase in serious antimicrobial drug resistant infections is a critical public health concern and a growing threat to patients. FDA is taking steps to combat antibiotic-resistant bacteria.

Tue, 12 Jun 2018 10:20:00 -0400


Statement from FDA Commissioner Scott Gottlieb, M.D., on new efforts to advance medical product communications to support drug competition and value-based health care
Statement from FDA Commissioner Scott Gottlieb, M.D., on new efforts to advance medical product communications to support drug competition and value-based health care

Tue, 12 Jun 2018 09:33:00 -0400


Federal judge enters consent decree against Delta Pharma
Federal judge enters consent decree against Delta Pharma

Fri, 08 Jun 2018 16:39:00 -0400


Statement from FDA Commissioner Scott Gottlieb, M.D., on 2017 National Youth Tobacco Survey results and ongoing FDA efforts to protect youth from the dangers of nicotine and tobacco products
Statement from FDA Commissioner Scott Gottlieb, M.D., on 2017 National Youth Tobacco Survey results and ongoing FDA efforts to protect youth from the dangers of nicotine and tobacco products

Thu, 07 Jun 2018 13:41:00 -0400